Orchard Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Orchard Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1346% to $6,986,000. The net income raised on -$7,883,000 and profit margin reached -113%. Total operating expenses were $36,145,000.
Profit Margin
| 2016 | 0 | -19.08M | |
|---|---|---|---|
| 2017 | 0 | -39.74M | |
| 2018 | 2.07M | -230.49M | -11102.84% |
| 2019 | 2.51M | -163.42M | -6503.06% |
| 2020 | 2.59M | -151.97M | -5856.61% |
| 2021 | 483K | -36.34M | -7525.67% |
| 2022 | 6.98M | -7.88M | -112.84% |
ORTX Income Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 6.98M | 483K | 2.59M | 2.51M | 2.07M | 0 | 0 |
Cost of revenue | 2.43M | 226K | 857K | 805K | 422K | 0 | 0 |
Gross profit | 4.55M | 257K | 1.73M | 1.70M | 1.65M | 0 | 0 |
Operating exp. | |||||||
Research and development | 25.54M | 23.34M | 93.73M | 117.36M | 205.31M | 32.52M | 16.20M |
Selling and marketing | 4.13M | 5.25M | 8.09M | 8.06M | 0 | 0 | 0 |
Total operating expenses | 36.14M | 36.89M | 158.71M | 174.58M | 236.68M | 38.51M | 19.20M |
Operating income | -31.59M | -36.41M | -156.97M | -172.87M | -235.03M | -38.51M | -19.20M |
Other income (expenses), net | 22.58M | 191K | 4.26M | 7.21M | 5.50M | -1.17M | 138K |
Income before tax | -9.01M | -36.22M | -152.71M | -165.66M | -229.52M | -39.69M | -19.06M |
Income tax expense | -1.12M | 125K | -731K | -2.24M | 970K | 53K | 20K |
Net income | -7.88M | -36.34M | -151.97M | -163.42M | -230.49M | -39.74M | -19.08M |
Earnings per share | |||||||
Basic EPS | -0.61 | -2.93 | -15.28 | -17.53 | -102.17 | -39.37 | -18.9 |
Diluted EPS | -0.61 | -2.93 | -15.28 | -17.53 | -102.17 | -39.37 | -18.9 |
| Data source | Data source | Data source | Data source | Data source |